Stem Cell Research & Cellular Therapy - Current State of the Marketplace
Conference Recording Jul 15, 2013
About the SpeakerEnal Razvi, PhD is biotechnology analyst at Select Biosciences. In this capacity he continuously tracks a number of fields in the scope of his industry coverage, authors market analysis reports in these areas, and works with companies worldwide in the areas of technology analysis, market research, strategy development, and operational roles. Dr. Razvi holds a doctoral degree in the biomedical sciences and was post-doctoral fellow under Ralph Steinman [Nobel Laureate in 2011] at The Rockefeller University, New York. For the last decade, Dr. Razvi has been focused on tracking the life sciences fields and has worked with numerous companies around the world.
This presentation describes the current state of the stem cells marketplace as it relates to their utilization for pharmaceutical screening as well as their development for cellular therapy. Details are provided about the quantitative market opportunity for various stem cell classes as well as the current state of the clinical trials space wherein stem cell-based therapeutics are being evaluated for therapy in various disease classes.